Neurology® Podcast

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial.  Disclosures can be found at Neurology.org.   

Dr. Dara Albert talks with Dr. Jon Stone about the latest advancements in FND from the recent International Conference on Functional Neurological Disorder. Dr. Jon Stone shares insights on the field's growth, multidisciplinary care, cultural perspectives, and future directions. Check out the FNDS website for more information about FND.  Disclosures can be found at Neurology.org. 

Dr. Stacey Clardy talks with Dr. John Ney about the link between military sexual trauma and migraine among US veterans.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Derek Stitt talks with Dr. Jennifer Morganroth about the evolving landscape of genetic testing in ALS, the importance of longitudinal care for at-risk individuals, and the capacity challenges faced by clinics.  Read the related article in Neurology® Genetics.  Disclosures can be found at Neurology.org. 

Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care.  Read the related article on The Conversation.  Disclosures can be found at Neurology.org. 

To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal's history, its evolution, and what lies ahead for the future of Neurology®.  Read more about the first 75 years of Neurology®.  Disclosures can be found at Neurology.org. 

Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care.  Read the related article in Neurology® Clinical Practice.   Disclosures can be found at Neurology.org. 

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding.  Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.  

The July 2026 Recall features four previously posted episodes related to updates in epilepsy. The episode opens with Dr. Rosemary Dray-Spira discussing trends in prenatal exposure to antiseizure medications over the past decade. The episode continues with Dr. Page Pennell discussing antiseizure medication management during pregnancy and postpartum. The episode then transitions into a conversation with Dr. Matthew Ryan Woodward on the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment. In the final episode, Dr. Stefano Meletti discusses the incidence and characteristics of postictal central apnea in focal seizures.  Podcast links:  Trends in Prenatal Exposure to Antiseizure Medications  Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD  Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication  Persistent Postictal Central Ap

Dr. Katie Krulisky talks with Dr. Marcus Pinto about the diagnosis and management of hereditary ATTR amyloidosis.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org.  

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent research presented at the 2026 European Stroke Organization Conference.  Read more about TAPIS trial.  Read more about the ODEA-TIA trial.  Disclosures can be found at Neurology.org.   

Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy.  Read more about this abstract.  Disclosures can be found at Neurology.org. 

Dr. Jeff Ratliff talks with Dr. Gabriela Figueiredo Pucci about how participation in a social media community influenced PIF and career development among neurology trainees.  Read the related article in Neurology® Education.  Disclosures can be found at Neurology.org. 

Dr. Stacey Clardy talks with Dr. John Ney about wait times for new neurology office visits among commercially insured persons in the United States.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org.  

Dr. Dan Ackerman talks with Dr. Reza Bavarsad Shahripour about the diagnostic performance of 4 major modalities: TCD, TTE, TEE, and cardiac CT in patients with embolic stroke of undetermined source.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Shuvro Roy talks with Dr. Amanda L. Piquet about the efficacy and safety of miv-cel in patients with stiff person syndrome.  Read more about this abstract on the AAN website.   Disclosures can be found at Neurology.org. 

In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care. Disclosures can be found at Neurology.org.

In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows. Disclosures can be found at Neurology.org. 

The June 2026 Recall highlights four previously posted episodes on parkinsonian disorders. The episode begins with Dr. Valtteri Kaasinen discussing the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. The discussion continues with Dr. YuHong Fu, who addresses the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. The third episode features Dr. Daniel Weintraub discussing clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. The episode concludes with Prof. Franziska Hopfner discussing the frequency and disease trajectory of MSA patients who do not experience dysautonomia, compared with those who have autonomic involvement. Podcast links:  Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years  Dementia with Lewy Bodies and Parkinson Disease Dementia Clinical Approach to Dementia Risk in Patients with Parkinson Disease

Dr. Gregg Day talks with Drs. Sonia Vallabh and Eric Minikel about scientific insights and the future of prion disease treatment, highlighting the importance of early diagnosis, personalized medicine, and hope for affected families.  Learn about the clinical trial.   Learn more about the Prion Alliance.  Disclosures can be found at Neurology.org.